Monday, July 7, 2008 - 18:28

Innate Pharma SA announces the outcome of its AGM that took place on June 27, 2008, in Marseilles and updates on the divestment process by Novo Nordisk A/S of its rights to IPH 2101.

AttachmentSize
PR in english84.7 KB
CP en français83.15 KB